Abstract

Many studies have shown that cellular morphology can be used to distinguish spiked-in tumor cells in blood sample background. However, most validation experiments included only homogeneous cell lines and inadequately captured the broad morphological heterogeneity of cancer cells. Furthermore, normal, non-blood cells could be erroneously classified as cancer because their morphology differ from blood cells. Here, we constructed a dataset of microscopic images of organoid-derived cancer and normal cell with diverse morphology and developed a proof-of-concept deep learning model that can distinguish cancer cells from normal cells within an unlabeled microscopy image. In total, more than 75,000 organoid-drived cells from 3 cholangiocarcinoma patients were collected. The model achieved an area under the receiver operating characteristics curve (AUROC) of 0.78 and can generalize to cell images from an unseen patient. These resources serve as a foundation for an automated, robust platform for circulating tumor cell detection.

Details

Title
Label-free tumor cells classification using deep learning and high-content imaging
Author
Piansaddhayanon, Chawan 1 ; Koracharkornradt, Chonnuttida 2 ; Laosaengpha, Napat 3 ; Tao, Qingyi 4 ; Ingrungruanglert, Praewphan 5 ; Israsena, Nipan 6 ; Chuangsuwanich, Ekapol 3 ; Sriswasdi, Sira 7   VIAFID ORCID Logo 

 Chulalongkorn University, Department of Computer Engineering, Faculty of Engineering, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875); Chulalongkorn University, Center of Excellence in Computational Molecular Biology, Faculty of Medicine, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875); Chulalongkorn University, Chula Intelligent and Complex Systems, Faculty of Science, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875) 
 Chulalongkorn University, Center of Excellence in Computational Molecular Biology, Faculty of Medicine, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875) 
 Chulalongkorn University, Department of Computer Engineering, Faculty of Engineering, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875); Chulalongkorn University, Center of Excellence in Computational Molecular Biology, Faculty of Medicine, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875) 
 NVIDIA AI Technology Center, Singapore, Singapore (GRID:grid.7922.e) 
 Chulalongkorn University, Center of Excellence for Stem Cell and Cell Therapy, Faculty of Medicine, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875) 
 Chulalongkorn University, Center of Excellence for Stem Cell and Cell Therapy, Faculty of Medicine, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875); Chulalongkorn University, Department of Pharmacology, Faculty of Medicine, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875) 
 Chulalongkorn University, Center of Excellence in Computational Molecular Biology, Faculty of Medicine, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875); Chulalongkorn University, Center for Artificial Intelligence in Medicine, Research Affairs, Faculty of Medicine, Bangkok, Thailand (GRID:grid.7922.e) (ISNI:0000 0001 0244 7875) 
Pages
570
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20524463
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2857486877
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.